VYNE Therapeutics’ mission is to improve the lives of patients by developing proprietary, innovative, and differentiated therapies for the treatment of immuno-inflammatory conditions.
| Website | https://www.vynetherapeutics.com/ |
| Ticker | MNLO |
| Employees | 65 (8 on RocketReach) |
| Founded | 2003 |
| Address | 520 U.S. Highway 22 Suite 204, Bridgewater, New Jersey 08807, US |
| Technologies |
JavaScript
,
HTML
,
PHP
+18 more
(view full list)
|
| Industry | Biotechnology |
| Keywords | Innovative Therapies, New Treatments, Therapeutic Solutions, Advanced Therapies, Biotechnology, Patient Care, Biopharma, Pharmaceutical Development, Health Solutions, Drug Development, Disease Treatment, Drug Discovery, Immunology Research, Medical Research, Clinical Trials, Inflammatory Diseases, Pharmaceutical Research |
| Competitors | Roche, Novartis, Pfizer, AstraZeneca, Amgen, Regeneron, Gilead Sciences, Vertex Pharmaceuticals, Biogen, Lilly India +39 more (view full list) |
Looking for a particular VYNE Therapeutics Inc. employee's phone or email?
David Domzalski is the CEO of VYNE Therapeutics Inc..
8 people are employed at VYNE Therapeutics Inc..
VYNE Therapeutics Inc. is based in Bridgewater, New Jersey.